These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 6353913
21. The physician strategies under payment reform affect hospital pharmacies. Wilson CN. Hosp Pharm; 1993 Apr; 28(4):352-4, 357. PubMed ID: 10125328 [No Abstract] [Full Text] [Related]
23. Reimbursement dilemma regarding home health-care products and services. Curtiss FR. Am J Hosp Pharm; 1984 Aug; 41(8):1548-57. PubMed ID: 6433706 [Abstract] [Full Text] [Related]
24. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period. Centers for Medicare and Medicaid Services (CMS), HHS. Fed Regist; 2006 Aug 18; 71(160):47869-8351. PubMed ID: 16921666 [Abstract] [Full Text] [Related]
25. Preparing for prospective payment policies. Nash DB. Med Mark Media; 1985 Aug 18; 20(8):10-1. PubMed ID: 10273664 [No Abstract] [Full Text] [Related]
26. Prospective-pricing strategies for hospital and departmental effectiveness: the physician's response. Shapleigh C. Am J Hosp Pharm; 1985 Oct 18; 42(10):2159-63. PubMed ID: 4061457 [Abstract] [Full Text] [Related]
27. Current concepts in hospital reimbursement. Curtiss FR. Am J Hosp Pharm; 1983 Apr 18; 40(4):586-91. PubMed ID: 6405615 [No Abstract] [Full Text] [Related]
28. A strategy to reduce drug expenditures with a drug utilization review program. Hoffmann RP. Hosp Pharm; 1984 Jan 18; 19(1):7-8, 11-2. PubMed ID: 10264746 [Abstract] [Full Text] [Related]
29. Indicators to control drug costs in hospitals. Mehl B. Am J Hosp Pharm; 1984 Apr 18; 41(4):667-75. PubMed ID: 6720708 [Abstract] [Full Text] [Related]
30. Physician payment 2008 for interventionalists: current state of health care policy. Manchikanti L, Giordano J. Pain Physician; 2007 Sep 18; 10(5):607-26. PubMed ID: 17876359 [Abstract] [Full Text] [Related]
31. Final regulations on Medicare prospective pricing. Curtiss FR. Am J Hosp Pharm; 1984 Apr 18; 41(4):716-20. PubMed ID: 6372451 [Abstract] [Full Text] [Related]
32. Medicare program; Medicare hospital reimbursement reforms: limitations on reimbursable costs and the rate of hospital cost increases--HCFA. Interim final rule with comment period. Fed Regist; 1982 Sep 30; 47(190):43282-93. PubMed ID: 10310162 [Abstract] [Full Text] [Related]
36. The use of ambulatory patient groups for regulation of hospital ambulatory surgery revenue in Maryland. Atkinson G, Murray R. J Ambul Care Manage; 2008 Dec 30; 31(1):17-23. PubMed ID: 18162791 [Abstract] [Full Text] [Related]
38. Involving physicians in efforts to control pharmaceutical expenditures. Shulkin DJ, McGourty ME, Bourret J. Med Interface; 1995 Aug 30; 8(8):85-7, 90. PubMed ID: 10144777 [Abstract] [Full Text] [Related]
39. Drug pricing and value in oncology. Danzon PM, Taylor E. Oncologist; 2010 Aug 30; 15 Suppl 1():24-31. PubMed ID: 20237214 [Abstract] [Full Text] [Related]
40. Methods of providing prescription drug benefits in health plans. Curtiss FR. Am J Hosp Pharm; 1986 Oct 30; 43(10):2428-35. PubMed ID: 3788994 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]